Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 5
66
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

COVID-19 and MOG-IgG–associated acquired demyelinating polyneuropathy compatible with chronic inflammatory demyelinating polyneuropathy in a previously healthy girl

, MDORCID Icon, , MD, , MD & , MD
Pages 719-721 | Received 22 Feb 2022, Accepted 03 Jun 2022, Published online: 17 Jun 2022

  • Kieseier BC, Mathey EK, Sommer C, Hartung HP. Immune-mediated neuropathies. Nat Rev Dis Primers. 2018;4(1):31. doi:10.1038/s41572-018-0027-2.
  • Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society—first revision. J Peripher Nerv Syst. 2010;15(4):295–301. doi:10.1111/j.1529-8027.2010.00290.x.
  • Md Noh MSF. Myelin oligodendrocyte glycoprotein-antibody (MOG-IgG) associated disease with centrally located long spinal cord lesion in a 14-month old child. J Cent Nerv Syst Dis. 2020;12:1179573520955008. doi:10.1177/1179573520955008.
  • Waters P, Fadda G, Woodhall M, et al; Canadian Pediatric Demyelinating Disease Network. Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes. JAMA Neurol. 2020;77(1):82–93. doi:10.1001/jamaneurol.2019.2940.
  • Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force—second revision. J Peripher Nerv Syst. 2021;26(3):242–268. doi:10.1111/jns.12455.
  • Luigetti M, Iorio R, Bentivoglio AR, et al; Gemelli Against COVID-19 Group. Assessment of neurological manifestations in hospitalized patients with COVID-19. Eur J Neurol. 2020;27(11):2322–2328. doi:10.1111/ene.14444.
  • Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R, Dawman L. Neurological complications of SARS-CoV-2 infection in children: a systematic review and meta-analysis. J Trop Pediatr. 2021;67(3) fmaa070. doi:10.1093/tropej/fmaa070.
  • Khalifa M, Zakaria F, Ragab Y, et al. Guillain-Barré syndrome associated with severe acute respiratory syndrome coronavirus 2 detection and coronavirus disease 2019 in a child. J Pediatric Infect Dis Soc. 2020;9(4):510–513. doi:10.1093/jpids/piaa086.
  • Manji HK, George U, Mkopi NP, Manji KP. Guillain-Barré syndrome associated with COVID-19 infection. Pan Afr Med J. 2020;35(Suppl 2):118. doi:10.11604/pamj.supp.2020.35.2.25003.
  • Naseri M, Ashrafzadeh F, Khademi G, Imannezhad S, Sorouri S, Sezavar M. COVID-19–associated acute transverse myelitis in children: a case report and review of literature. J Pediatr Rev. 2022;10:433–438.
  • Curtis M, Bhumbra S, Felker MV, et al. Guillain-Barré syndrome in a child with COVID-19 infection. Pediatrics. 2021;147(4):e2020015115. doi:10.1542/peds.2020-015115.
  • Araújo NM, Ferreira LC, Dantas DP, et al. First report of SARS-CoV-2 detection in cerebrospinal fluid in a child with Guillain-Barré syndrome. Pediatr Infect Dis J. 2021;40(7):e274–e276. doi:10.1097/INF.0000000000003146.
  • Khera D, Didel S, Panda S, Tiwari S, Singh K. Concurrent longitudinally extensive transverse myelitis and Guillain-Barré syndrome in a child secondary to COVID-19 infection: a severe neuroimmunologic complication of COVID-19. Pediatr Infect Dis J. 2021;40(6):e236–e239. doi:10.1097/INF.0000000000003124.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.